Archives
-
Polyphyllin H Reverses Paclitaxel Resistance
2026-10-01
The reference study identifies membrane cholesterol and lipid rafts as a shared regulatory vulnerability in paclitaxel-resistant breast cancer. Polyphyllin H binds membrane cholesterol, suppresses ABCB1 and ABCC3-associated drug efflux, increases intracellular paclitaxel, and restores treatment sensitivity in cellular and in vivo models.
-
DAPT (GSI-IX): γ-Secretase Research Guide
2026-09-30
DAPT, also called GSI-IX, is a selective γ-secretase inhibitor used to modulate amyloid precursor protein processing and Notch signaling. Its reported cellular benchmarks and corneal epithelial-cell application support controlled pathway studies, while product handling and context-dependent biology limit direct therapeutic interpretation.
-
SW033291 Workflows for 15-PGDH Research
2026-09-30
Build a translational workflow around SW033291, from nanomolar enzyme inhibition and prostaglandin E2 elevation to hematopoiesis and muscle-repair assays. The guide separates validated product performance from practical optimization choices so researchers can test regeneration biology without overextending preclinical evidence.
-
SOAT1, Lipophagy, and PHMG Pulmonary Fibrosis
2026-09-29
The 2026 Biochemical Pharmacology study identifies SOAT1 as a previously unrecognized mediator of PHMG-induced pulmonary fibrosis, linking alveolar-macrophage cholesterol esterification to defective lipophagy and foam-cell-driven fibroblast activation. Its mouse, macrophage, and pharmacological evidence positions SOAT1 inhibition as a preclinical strategy while clarifying how cholesterol measurements can support, but not replace, mechanistic fibrosis assays.
-
Metformin HCl: From Metabolism to Tendon HO
2026-09-29
Metformin Hydrochloride is more than a glucose-lowering research tool: it provides a framework for connecting cellular metabolism with tendon-derived stem-cell fate. This article translates evidence on AMPK, mGPD, Nr4a1, and Wnt/β-catenin signaling into practical assay-design decisions.
-
DeferoxamineB in Ferroptosis Assay Design
2026-09-28
DeferoxamineB is a practical iron-dependency probe for cancer cell assays, helping researchers distinguish ferroptotic, apoptotic, and autophagic responses. This guide combines formulation guidance with a metabolic intervention framework inspired by recent ferroptosis/cuproptosis research.
-
Bafilomycin A1: Reliable Lysosomal Assay Design
2026-09-28
A practical, scenario-driven guide to using Bafilomycin A1 (SKU A8627) to investigate lysosomal function, intracellular pH regulation, and cell-assay variability. It covers dose selection, controls, interpretation, and product-selection considerations without treating a mechanistic inhibitor as a neutral viability reagent.
-
Butylated Hydroxyanisole (BHA) in Redox Assays
2026-09-27
Use Butylated hydroxyanisole (BHA) as a controlled redox perturbation to test how oxidative conditions influence cellular readouts—not as a stand-alone proof of a specific pathway. This guide pairs practical dose-finding and assay controls with a peptide structure–activity study, while clearly distinguishing that study’s findings from BHA evidence.
-
HyperScribe™ mRNA Synthesis for Cell Engineering
2026-09-26
Explore how mRNA synthesis supports cell-engineering studies, using HyperScribe™ All in One mRNA Synthesis Kit II (EZ Cap Reagent AG (3' OMe), T7, poly(A)) as a research workflow example. A recent intervertebral disc study illustrates why transcript design, delivery, and the inflammatory environment must be evaluated as separate but connected variables.
-
DAPT (GSI-IX): Notch Signaling Evidence & Workflow
2026-09-25
DAPT (GSI-IX) is a γ-secretase inhibitor used to reduce amyloid-β production and modulate Notch-dependent biology. Its use in thymic epithelial cell programming is a testable research application, not a DAPT-specific protocol established by the cited FOXN1 study.
-
Exo1 and the Next Questions in Tumor Vesicle Biology
2026-09-25
Exo1 offers a way to acutely perturb Golgi-to-ER traffic and ask more precise questions about secretion. This article connects its mechanism to emerging tumor extracellular vesicle research while distinguishing a useful experimental hypothesis from an established therapeutic claim.
-
AMPK–p62 Feedback Links Metabolic Stress to NRF2
2026-09-24
A 2024 study describes a double-positive feedback loop between AMPK and SQSTM1/p62 that coordinates AMPK and NRF2 activation during metabolic stress. The findings connect lysosomal pH changes to antioxidant defense and offer a mechanistic framework for understanding metabolic adaptation in STK11- and KEAP1-altered lung cancer.
-
Candida EVs, Nrg1, and Hyphal Suppression
2026-09-24
This study reports that high levels of Candida albicans extracellular vesicles suppress hyphal development by increasing NRG1 expression, with SKO1 and BRG1 implicated in the regulatory pathway. The genetic and mouse-model findings connect this response to reduced fungal burden and improved survival, while leaving the responsible EV cargo and its relevance to human infection for further study.
-
Superoxide Dismutase (SOD) Activity Assay Kit Guide
2026-09-23
The Superoxide Dismutase Activity Assay Kit (K2035) measures SOD activity through inhibition of WST-1 formazan formation in a xanthine oxidase-driven colorimetric reaction. It is intended for research measurements in biological fluids—not for diagnosis, clinical decisions, or direct quantification of superoxide concentration.
-
Proteinase K Workflows for DNA and EV Research
2026-09-23
Learn how Proteinase K supports genomic DNA isolation, contaminant removal, and controlled protein hydrolysis without sacrificing nucleic-acid quality. A Candida albicans extracellular-vesicle study provides a practical model for designing protease-sensitive controls and interpreting protein-dependent phenotypes.